Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0533
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis ; volume:144 ; number:3 ; day:1 ; month:7 ; year:2022 ; pages:413-435 ; date:9.2022
Acta neuropathologica ; 144, Heft 3 (1.7.2022), 413-435, 9.2022
- Creator
-
Krach, Florian
Wheeler, Emily C.
Regensburger, Martin
Boerstler, Tom
Wend, Holger
Vu, Anthony Q.
Wang, Ruth
Reischl, Stephanie
Boldt, Karsten
Batra, Ranjan
Aigner, Stefan
Ravits, John
Winkler, Juergen
Yeo, Gene W.
Winner, Beate
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-022-02450-3
- URN
-
urn:nbn:de:101:1-2022110320573554814246
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Krach, Florian
- Wheeler, Emily C.
- Regensburger, Martin
- Boerstler, Tom
- Wend, Holger
- Vu, Anthony Q.
- Wang, Ruth
- Reischl, Stephanie
- Boldt, Karsten
- Batra, Ranjan
- Aigner, Stefan
- Ravits, John
- Winkler, Juergen
- Yeo, Gene W.
- Winner, Beate
- SpringerLink (Online service)
Other Objects (12)
Aberrant alternative splicing: the molecular hallmark of sporadic amyotrophic lateral sclerosis and beyond
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis and cerebellum
Genetics of Amyotrophic Lateral Sclerosis
Aberrant splicing and drug resistance in AML
Recent advances in amyotrophic lateral sclerosis
Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
A novel splicing variant of ANXA11 in a patient with amyotrophic lateral sclerosis: histologic and biochemical features
Mice with endogenous TDP ‐43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis
Investigating aberrant granulostasis and impaired protein homeostasis in P525L FUS-amyotrophic lateral sclerosis using iPSC-derived neurons
Genetics and epigenetics of amyotrophic lateral sclerosis
Aberrant alternative splicing: the molecular hallmark of sporadic amyotrophic lateral sclerosis and beyond
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis and cerebellum
Genetics of Amyotrophic Lateral Sclerosis
Aberrant splicing and drug resistance in AML
Recent advances in amyotrophic lateral sclerosis
Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
A novel splicing variant of ANXA11 in a patient with amyotrophic lateral sclerosis: histologic and biochemical features
Mice with endogenous TDP ‐43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis
Investigating aberrant granulostasis and impaired protein homeostasis in P525L FUS-amyotrophic lateral sclerosis using iPSC-derived neurons
Genetics and epigenetics of amyotrophic lateral sclerosis
Aberrant alternative splicing: the molecular hallmark of sporadic amyotrophic lateral sclerosis and beyond
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis and cerebellum
Genetics of Amyotrophic Lateral Sclerosis
Aberrant splicing and drug resistance in AML
Recent advances in amyotrophic lateral sclerosis
Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
A novel splicing variant of ANXA11 in a patient with amyotrophic lateral sclerosis: histologic and biochemical features
Mice with endogenous TDP ‐43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis
Investigating aberrant granulostasis and impaired protein homeostasis in P525L FUS-amyotrophic lateral sclerosis using iPSC-derived neurons